Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Cerebellum. 2022 Aug 12;22(5):790–809. doi: 10.1007/s12311-022-01424-1

Table 4.

Correlations against the S-Factor

SCA1 SCA2 SCA3 SCA6
SARA r(80)=0.544, p<.001 r(79)=0.412, p<.001 r(201)=0.524, p<.001 r(70)=0.442, p<.001
BARS r(12)=0.485, p=.079 r(15)=0.554, p=.021 r(27)=0.430, p=.020 r(11)=0.764, p=.002
Functional stage r(66)=0.479, p<.001 r(76)=0.259, p=.022 r(167)=0.562, p<.001 r(70)=0.495, p<.001
CCFS r(15)=−0.046, p=.860 N/A r(46)=0.361, p=.012 N/A
25-foot walk test r(65)=0.269, p=.028^ r(60)=0.116, p=.369^ r(164)=0.268, p<.001 r(60)=0.323, p=.011
CCAS-S raw r(24)=−0.129, p=.529 r(15)=−0.372, p=.141 r(62)=−0.129, p=.308 r(13)=-0.05, p=.860
CCAS-S fail r(24)=0.283, p=.161 r(15)=0.303, p=.236 r(60)=0.063, p=.627^ r(13)=0.003, p=.992

Notes: Number in brackets refers to number of degrees of freedom for the correlation; number of participants included in the correlation is 2 more than this value. SARA, Scale for the Assessment and Rating of Ataxia; BARS, Brief Ataxia Rating Scale; CCFS, Composite Cerebellar Functional Severity Score; CCAS-S, Cerebellar Cognitive Affective/Schmahmann Syndrome Scale

^

An outlier or outliers was excluded from the correlation due to having a notable influence on the analysis